These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38586613)

  • 21. Uterine-preserving surgeries for the repair of pelvic organ prolapse: a systematic review with meta-analysis and clinical practice guidelines.
    Meriwether KV; Balk EM; Antosh DD; Olivera CK; Kim-Fine S; Murphy M; Grimes CL; Sleemi A; Singh R; Dieter AA; Crisp CC; Rahn DD
    Int Urogynecol J; 2019 Apr; 30(4):505-522. PubMed ID: 30741318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse.
    Pan K; Cao L; Ryan NA; Wang Y; Xu H
    Int Urogynecol J; 2016 Jan; 27(1):93-101. PubMed ID: 26179552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term reoperation risk after apical prolapse repair in female pelvic reconstructive surgery.
    Shah NM; Berger AA; Zhuang Z; Tan-Kim J; Menefee SA
    Am J Obstet Gynecol; 2022 Aug; 227(2):306.e1-306.e16. PubMed ID: 35654112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of colpopexy and colporrhaphy at the time of hysterectomy for prolapse.
    Fairchild PS; Kamdar NS; Berger MB; Morgan DM
    Am J Obstet Gynecol; 2016 Feb; 214(2):262.e1-262.e7. PubMed ID: 26366666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apical suspension is underutilized for repair of stage IV pelvic organ prolapse: an analysis of national practice patterns in the United States.
    Slopnick EA; Chapman GC; Roberts K; Sheyn DD; El-Nashar S; Mahajan ST
    Int Urogynecol J; 2021 Apr; 32(4):791-797. PubMed ID: 32507910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the Value of Uterus instrument and visual analog scale to measure patients' valuation of their uterus.
    Chang OH; Walters MD; Yao M; Lapin B
    Am J Obstet Gynecol; 2022 Nov; 227(5):746.e1-746.e9. PubMed ID: 35764134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications and objective outcomes of uterine preserving surgeries for the repair of pelvic organ prolapse versus procedures removing the Uterus, a systematic review.
    Azadi A; Marchand G; Masoud AT; Sainz K; Govindan M; Ware K; King A; Ruther S; Brazil G; Calteux N; Ulibarri H; Parise J; Arroyo A; Coriell C; Goetz S; Ostergard DR
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():90-98. PubMed ID: 34736035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Urinary Outcomes After Transvaginal Uterovaginal Prolapse Repair With and Without Concomitant Midurethral Slings.
    Giugale L; Sridhar A; Ferrante KL; Komesu YM; Meyer I; Smith AL; Myers D; Visco AG; Paraiso MFR; Mazloomdoost D; Gantz M; Zyczynski HM;
    Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):142-148. PubMed ID: 35272320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of uterine preservation on outcome of laparoscopic uterosacral suspension.
    Bedford ND; Seman EI; O'Shea RT; Keirse MJ
    J Minim Invasive Gynecol; 2013; 20(2):172-7. PubMed ID: 23321154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol).
    van IJsselmuiden MN; Coolen AL; Detollenaere RJ; den Boon J; Bongers M; van de Pol G; Vollebregt A; Radder CM; Deprest J; van Eijndhoven HW
    BMC Womens Health; 2014 Sep; 14():112. PubMed ID: 25231240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of lower urinary tract injury with laparoscopic sacrocolpopexy.
    Welch EK; Dengler KL; Guirguis M; Strauchon C; Olsen C; Von Pechmann W
    AJOG Glob Rep; 2022 Feb; 2(1):100035. PubMed ID: 36274961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hysteropexy: an Option for the Repair of Pelvic Organ Prolapse.
    Bradley S; Gutman RE; Richter LA
    Curr Urol Rep; 2018 Feb; 19(2):15. PubMed ID: 29476274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.
    Hemming C; Constable L; Goulao B; Kilonzo M; Boyers D; Elders A; Cooper K; Smith A; Freeman R; Breeman S; McDonald A; Hagen S; Montgomery I; Norrie J; Glazener C
    Health Technol Assess; 2020 Mar; 24(13):1-220. PubMed ID: 32138809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic sacrohysteropexy versus vaginal hysterectomy and apical suspension: 7-year follow-up of a randomized controlled trial.
    Izett-Kay ML; Rahmanou P; Cartwright RJ; Price N; Jackson SR
    Int Urogynecol J; 2022 Jul; 33(7):1957-1965. PubMed ID: 34424347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reoperation for prolapse recurrence after sacrospinous mesh hysteropexy: characteristics of women choosing retreatment.
    Napoe GS; Luchristt D; Sridhar A; Ellington D; Ridgeway B; Mazloomdoost D; Sung V; Ninivaggio C; Harvie H; Santiago-Lastra Y; Gantz MG; Zyczynski HM
    Int Urogynecol J; 2023 Jan; 34(1):255-261. PubMed ID: 36449027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic sacral hysteropexy versus laparoscopic sacral colpopexy plus supracervical hysterectomy in patients with pelvic organ prolapse.
    Campagna G; Vacca L; Panico G; Rumolo V; Caramazza D; Lombisani A; Rossitto C; Gadonneix P; Scambia G; Ercoli A
    Int Urogynecol J; 2022 Feb; 33(2):359-368. PubMed ID: 34132865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of apical vaginal support procedures at time of inpatient hysterectomy performed for benign conditions: a national estimate.
    Ross WT; Meister MR; Shepherd JP; Olsen MA; Lowder JL
    Am J Obstet Gynecol; 2017 Oct; 217(4):436.e1-436.e8. PubMed ID: 28716634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic hysteropexy: the initial results of a uterine suspension procedure for uterovaginal prolapse.
    Price N; Slack A; Jackson SR
    BJOG; 2010 Jan; 117(1):62-8. PubMed ID: 20002370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Risk of Primary Uterine and Cervical Cancer After Hysteropexy.
    Kurian R; Kirchhoff-Rowald A; Sahil S; Cheng AL; Wang X; Shepherd JP; Sutkin G
    Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):e493-e496. PubMed ID: 33620910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Does hysterectomy modifies the anatomical and functional outcomes of prolapse surgery?: Clinical Practice Guidelines].
    Cayrac M; Warembourg S; Le Normand L; Fatton B
    Prog Urol; 2016 Jul; 26 Suppl 1():S73-88. PubMed ID: 27595628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.